Levomilnacipran
These highlights do not include all the information needed to use LEVOMILNACIPRAN EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for LEVOMILNACIPRAN EXTENDED-RELEASE CAPSULES. LEVOMILNACIPRAN extended-release capsules, for oral use Initial U.S. Approval: 2009 (milnacipran)
bcbc5d92-e022-4a0d-ab4d-2b0d7aa68c58
HUMAN PRESCRIPTION DRUG LABEL
Nov 16, 2023
Amneal Pharmaceuticals LLC
DUNS: 123797875
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Levomilnacipran
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (19)
Levomilnacipran
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (19)
Levomilnacipran
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (19)
Levomilnacipran
Product Details
FDA regulatory identification and product classification information